Green tea: Potential health benefits

American Family Physician

Volumn 79, Issue 7, 2009, Pages 591-594

  Schneider, Craig ^a   Segre, Tiffany ^b  

^a MAINE MEDICAL CENTER   (United States)

^b Gorham Family Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CAFFEINE; CHOLESTEROL; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POLYPHENOL; SINECATECHIN DERIVATIVE; TEAFLAVIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEREGEN; WARFARIN;

ADVANCED CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONDYLOMA ACUMINATUM; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ESOPHAGUS CANCER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; LIVER TOXICITY; MORTALITY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SKIN IRRITATION; STOMACH CANCER; STROKE; TEA; UTERINE CERVIX DISEASE; WEIGHT REDUCTION; ALTERNATIVE MEDICINE; BEVERAGE; METHODOLOGY; NEOPLASM; PROGNOSIS;

BEVERAGES; CARDIOVASCULAR DISEASES; COMPLEMENTARY THERAPIES; HUMANS; NEOPLASMS; PROGNOSIS; TEA;

EID: 65549123037     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Schardt D. Does tea ward off disease? Nutr Action Healthletter. 2007;34(2):9-11.
2. Patel SH. Camellia sinensis: historical perspectives and future prospects. J Agromedicine. 2005;10(2):57-64. (Pubitemid 43078271)
3. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea - a review. J Am Coll Nutr. 2006;25(2):79-99. (Pubitemid 46939847)
4. Gross G, et al. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol. 2007;21(10):1404-1412. (Pubitemid 350020150)
5. U.S. Food and Drug Administration. Veregen (Kunecatechins) ointment, 15%. http://www.fda.gov/cder/foi/label/2006/021902lbl.pdf. Accessed December 22, 2008.
6. Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev. 2003;12(5):383-390. (Pubitemid 37338812)
7. Bushman JL. Green tea and cancer in humans: a review of the literature. Nutr Cancer. 1998;31(3):151-159. (Pubitemid 28481848)
8. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006;27(7):1310-1315. (Pubitemid 43985405)
9. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006;27(7):1301-1309. (Pubitemid 43985404)
10. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10):1255-1265. (Pubitemid 44394897)
11. Sun CL, Yuan JM, Lee MJ, et al. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis. 2002;23(9):1497-1503. (Pubitemid 35012430)
12. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66(2):1234-1240. (Pubitemid 43165995)
13. Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol. 2005;23(2):108-113. (Pubitemid 40616301)
14. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, for the JPHC Study Group. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 2008;167(1):71-77.
15. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr. 2004;91(3):431-437. (Pubitemid 38386907)
16. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav. 2006;87(1):185-191. (Pubitemid 41797739)
17. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005;13(7):1195-1204.
18. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473-1483.
19. Tsubono Y, Tsugane S. Green tea intake in relation to serum lipid levels in Middle-aged Japanese men and women. Ann Epidemiol. 1997;7(4):280-284. (Pubitemid 27248651)
20. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003;163(12):1448-1453. (Pubitemid 36758917)
21. Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol. 2005;17(10):1135-1137. (Pubitemid 41424011)
22. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother. 1999;33(4):426-428. (Pubitemid 29215809)
23. Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, Durrant MC, Thorneley RN, Rodríguez-López JN. The antifolate activity of tea catechins. Cancer Res. 2005;65(6):2059-2064. (Pubitemid 40490108)